UroGen Pharma Ltd. (FRA:UR8)

UroGen Pharma Revenue

UroGen Pharma had revenue of $27.48M USD in the quarter ending September 30, 2025, with 9.04% growth. This brings the company's revenue in the last twelve months to $96.52M, up 8.00% year-over-year. In the year 2024, UroGen Pharma had annual revenue of $90.40M with 9.29% growth.

• Revenue (ttm): $96.52M
• Revenue Growth: +8.00%
• P/S Ratio: 13.93
• Revenue / Employee: $410.71K
• Employees: 235
• Market Cap: 1.15B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	90.40M	7.69M	9.29%
Dec 31, 2023	82.71M	18.36M	28.52%
Dec 31, 2022	64.36M	16.32M	33.96%
Dec 31, 2021	48.04M	36.24M	307.17%
Dec 31, 2020	11.80M	11.78M	65,450.00%
Dec 31, 2019	18.00K	-1.11M	-98.40%
Dec 31, 2018	1.13M	-7.03M	-86.17%
Dec 31, 2017	8.16M	-9.37M	-53.46%
Dec 31, 2016	17.53M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-